John Pascoe
Psychiatry · Dallas, TXNPI 1467460774
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 1 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. Every reported general payment came from a single manufacturer, Merck. That places this record below the midpoint for psychiatry clinicians in TX, where the typical reported total is $228.
Across 1 payment — averaging $32.40 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Merck$32
Across 317 payments — averaging $7309.70 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- AbbVie$1.7M
- Otsuka Pharmaceutical Development & Commercialization, Inc.$283K
- Corcept Therapeutics$127K
- Sage Therapeutics, LLC$98K
- Alkermes, Inc.$77K
- E.r. Squibb & Sons, L.L.C.$6K
- plus $5K from 1 others
What the payments were for
- Food & beverage$32100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Merck | 1 | $32 |
How this compares
$32 in reported general payments places this provider in the 20th percentile of 2,238 psychiatry providers in Texas.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BelsomraSuvorexant | 11 | $4,597 |
| Bupropion XlBupropion Hcl | 87 | $1,873 |
| Mirtazapine | 37 | $602 |
| Dextroamphetamine-Amphet ErDextroamphetamine/Amphetamine | 11 | $517 |
| Clonazepam | 58 | $477 |
| Fluoxetine Hcl | 45 | $367 |
| Trazodone Hcl | 12 | $209 |
| Zolpidem Tartrate | 11 | $172 |
| Alprazolam | 14 | $49 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| MerckBelsomra | $32 | $4,59711 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 20th percentile of 2,238 psychiatry providers in Texas.
Other psychiatry in Dallas
- Joel HolinerDallas$948K
- Augustus RushDallas$760K
- Darin OkudaDallas$402K
- Stephen VobachDallas$278K
- Carolyn RekerdresDallas$259K
- Madhukar TrivediDallas$209K
- Ella DalyDallas$67K
- Rakesh JainLake Jackson$7.2M
- Arvinder Pal WaliaAustin$2.5M
- Suresh SureddiPlano$2.2M
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.